Sepsis
1,553
183
209
774
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
82 trials with published results (5%)
Research Maturity
774 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
59 terminated out of 1553 trials
92.9%
+6.4% vs benchmark
12%
186 trials in Phase 3/4
11%
82 of 774 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 774 completed trials
Clinical Trials (1553)
Cardiovascular Magnetic Resonance Prognosticators in Pediatric Oncology Patients With Sepsis
A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy
Sepsis Multiomic Analysis & Risk sTratification in China
Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis
Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis
Evaluation of the Performance of the IDBIORIV Method in Pathogen Identification and Antibiotic Susceptibility Testing in Patients With Sepsis
Self-directed Mobile Mindfulness to Address ICU Survivors' Psychological Distress: the Lift RCT
Safety and Feasibility of Metformin for Sepsis Induced AKI
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury
Smart Discharges for Older Children
ObsErvational Study of the Practical Cinical UTility of the NuQ.® H3.1 Nucleosome Levels in Adult Patients With Sepsis to Facilitate Early Diagnosis and Prognostication. (EPICETUS)
Nafamostat Mesylate Versus Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy in Sepsis-Associated Acute Kidney Injury
miRNA in Septic Acute Kidney Injury
Adjunctive Fludrocortisone in Septic Shock
Plasma Free Fatty Acids in Risk Assessment of Sepsis in the Emergency Department: A Prospective Pilot Study
STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis
Delphi Septic Shock: Sub-phenotypes Using Point-of-Care Ultrasound in Patients With Septic Shock
Recovery of Physical Function After Critical Illness In Older Adults
Racecadotril for Organ Injury in Sepsis Patients